Chance Pharmaceuticals
About:
Chance Pharmaceuticals is a clinical-stage biotechnology company focusing on discovering.
Website: http://www.chancepharmaceuticals.com/
Top Investors: Fortune Venture Capital, Delian Capital, Shenzhen Guozhong Venture Capital Management, Kaitai Capital, Lapam Capital
Description:
Chance Pharmaceuticals provides, discovers, develops, and commercializes inhalation therapies for the world’s debilitating diseases such as chronic obstructive pulmonary disease, asthma, pulmonary arterial hypertension, and central nervous system disorders.
Total Funding Amount:
$51.3M
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2015-01-01
Founders:
Donghao Chen, James Huang
Number of Employees:
1-10
Last Funding Date:
2022-01-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai